Drugs are developed for what is believed to be the “average patient,” even though there’s no such thing, and patients are prescribed drug after drug until, hopefully, they find one that works. Meanwhile, they’re putting their lives on hold while their disease worsens and billions of dollars are wasted in prescription costs.
Now, with our breakthrough ability to determine which drug will work best for each patient, we can do better to advance precision medicine in autoimmune diseases.
Fueled by our platform and the data from our diagnostic tests, we are rescuing drugs for those who do not respond to current treatments in the market by improving patient stratification.
Our platform uses the largest protein interaction database ever built to better understand diseases and how to treat them. As more data is added, we will be able to improve patients’ treatment options to help them get the right treatment.
Fueled by our platform and the data from our diagnostics, we identify novel targets for new therapies and the appropriate patient population who are more likely to respond to the drug.